rxstat › Shortages › Naproxen
Naproxen shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Naproxen products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 25, 2024.
In shortage since
Jul 25, 2024
Est. full return
Dec 25, 2024
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageANAPROX
275MG · TABLET · ATNAHS PHARMA UK LIMITED
DIN 02162725 · since Jul 25, 2024, est. end Dec 25, 2024 · Other (Please describe in comments)
ResolvedTEVA-NAPROXEN SODIUM DS
550MG · TABLET · TEVA CANADA LIMITED
DIN 02026600 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-NAPROXEN SODIUM
275MG · TABLET · TEVA CANADA LIMITED
DIN 00778389 · ended Feb 18, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-NAPROXEN SODIUM DS
550MG · TABLET · TEVA CANADA LIMITED
DIN 02026600 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-NAPROXEN SODIUM DS
550MG · TABLET · TEVA CANADA LIMITED
DIN 02026600 · ended Aug 19, 2025 · Disruption of the manufacture of the drug.
DiscontinuedTEVA-NAPROXEN SODIUM
275MG · TABLET · TEVA CANADA LIMITED
DIN 00778389
ResolvedTEVA-NAPROXEN SODIUM
275MG · TABLET · TEVA CANADA LIMITED
DIN 00778389 · ended Jan 7, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-NAPROXEN SODIUM DS
550MG · TABLET · TEVA CANADA LIMITED
DIN 02026600 · ended Nov 8, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-NAPRO-NA DS
550MG · TABLET · APOTEX INC
DIN 01940309 · ended Jul 26, 2023 · Disruption of the manufacture of the drug.
ResolvedANAPROX
275MG · TABLET · ATNAHS PHARMA UK LIMITED
DIN 02162725 · ended May 25, 2023 · Shortage of an active ingredient.
ResolvedAPO-NAPRO-NA DS
550MG · TABLET · APOTEX INC
DIN 01940309 · ended Aug 23, 2022 · Disruption of the manufacture of the drug.
ResolvedAPO-NAPRO-NA
275MG · TABLET · APOTEX INC
DIN 00784354 · ended Aug 19, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 27 reports. All reports are on file with Health Canada.
What's happening
Naproxen is currently affected by an active shortage report filed with Health Canada by ATNAHS PHARMA UK LIMITED.
The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Naproxen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).
Recent changes
Common questions
When will Naproxen be back in stock in Canada?
The latest manufacturer estimate is Dec 25, 2024. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Naproxen in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.